In remarks at the CHEST 2022 Opening Session, CHEST President-Elect, Doreen J. Addrizzo-Harris, MD, FCCP, announced a focus on strengthening CHEST membership; expanding diversity, equity, and inclusion initiatives; and much more.
Fellows from Brooke Army Medical Center, Mayo Clinic, and NewYork-Presbyterian Brooklyn Methodist navigated skills challenges and creative clinical trivia during the championship event at CHEST 2022 in Nashville.
Palak Rath, MD, and other presenters shared abstracts at CHEST 2022 exploring the effects of limited ICU resource levels on patients as well as new technologies and approaches that could help improve care.
David E. Griffith, MD, FCCP, opened a CHEST 2022 discussion on the challenges of caring for nontuberculous mycobacteria infections by going over recently published data, including some focusing on amikacin liposome inhalation suspension and Mycobacterium abscessus.
“Aloha embodies all of the characteristics that humanize being a care provider and bring us together. At CHEST 2023, we will truly celebrate our vocation and dedication to healing,” said Aneesa Das, MD, FCCP, chair, CHEST 2023 Scientific Program Committee.
During a session Tuesday, October 18, Chenell Donadee, MD, and fellow panelists staked out stances on the use of physiologic scoring systems to allocate life-prolonging resources during a crisis.
Peter J. Mazzone, MD, MPH, FCCP, and two other experts reviewed recent changes to lung cancer screening guidelines during a session on October 18 and discussed their impact on historic disparities.
Kamran Mahmood, MD, MPH, will chair a discussion that will explore current approaches to pneumothorax and persistent air leak from a multidisciplinary perspective.
Alice Gallo De Moraes, MD, will chair an interactive review of severe asthma in the ICU that will rely on the audience to choose and discuss the best treatments and strategies.
Parijat Sen, MD, MBBS, FCCP, will help discuss the identification and management of key extrapulmonary manifestations of sarcoidosis during a panel Wednesday afternoon.
Ashley Marie Scott, MD, will help discuss the current evidence for and against the administration of different coagulation factors prior to ICU procedures during a panel discussion Wednesday.
A. Christine Argento, MD, FCCP, will chair a groundbreaking session on current evidence and future pathways for intratumoral therapy in lung cancer treatment.